Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
Exelixis, Inc. (EXEL)
Last exelixis, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-mediaresources
Company Research
Source: Seeking Alpha
Michael Morrissey - CEO, President & Director Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division Welcome to this next fireside chat with Exelixis. With us today, we have Mike Morrissey, President and CEO. Mike, welcome. Thanks for joining us again. Michael Morrissey CEO, President & Director Great to be here, Michael. Thanks for the invite. Before we begin, I'll be making forward-looking statements. So please see our SEC filings for a description of the risks that we face in our business. Michael Schmidt Guggenheim Securities, LLC, Research Division Sounds good. Great. Thank you, Mike. So Mike, there are a lot of moving parts at Exelixis. You have the commercial story with CABOMETYX. You have recent and upcoming data card flips for zanzalintinib, your key pipeline product, and you have an evolving early-stage pipeline. And so before we jump into
Show less
Read more
Impact Snapshot
Event Time:
EXEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXEL alerts
High impacting Exelixis, Inc. news events
Weekly update
A roundup of the hottest topics
EXEL
News
- Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025Business Wire
- Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- Company News for Nov 6, 2025 [Yahoo! Finance]Yahoo! Finance
- Exelixis: The STELLAR Win Is A Mixed Bag, But Things Look Positive Still [Seeking Alpha]Seeking Alpha
- Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in NovemberBusiness Wire
EXEL
Earnings
- 11/4/25 - Beat
EXEL
Sec Filings
- 11/26/25 - Form 4
- 11/24/25 - Form 4
- 11/24/25 - Form 4
- EXEL's page on the SEC website